Get ready for the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) in Amsterdam, the Netherlands, on 22-23 April, where regional partners unite to drive industry transformation through green solutions and cutting-edge technologies.

BGS Group proudly hosts the esteemed partners of PHARMAP 2024, including MSD, Organon, Produlab Pharma, Johnson & Johnson Innovative Medicine, and Echo Pharmaceuticals, all committed to fostering a sustainable future and impactful pharmaceutical solutions.

The event kicks off with an executive panel discussion on new models for pharma manufacturing and packaging, featuring CEOs, CFOs, managing directors, and board members. Maria Romano from MSD shares insights on supply planning team readiness for organizational transformations.

Dolf Kroep, Director of Supply Chain Management at Organon, unveils the company's global supply network reconfiguration and transformative supply chain strategies during the opening panel.

Day two features Maurice Janssen from Organon discussing facility design futures and global facility management trends, emphasizing sustainability, energy efficiency, and environmental monitoring.

Amin Qureishi, from Produlab Pharma, presents the company's sustainability initiatives, highlighting its role as an independent veterinary CMO and its comprehensive support throughout the pharmaceutical development lifecycle.

Johnson & Johnson Innovative Medicine showcases its commitment to sustainability through product innovation processes, integrating sustainable design solutions and considering environmental impacts.

Echo Pharmaceuticals, specializing in cannabis-derived medicines and products, joins as a regional partner, showcasing advanced extraction, purification, formulation, and delivery technologies.

PHARMAP 2024, with its regional partners, aims to revolutionize the pharmaceutical landscape, paving the way for sustainable advancements and next-generation technologies.